Milestone Pharmaceuticals Inc (MIST NASDAQ) stock market data APIs
$1.0922
-0.02(-1.8%)
as of August 14, 2026
Try our APIs with
free plan!
Milestone Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Prev. Close
1.0922
Open
1.0755
High
1.0929
Low
1.0451
52 wk Range
1-3.06
Market Cap
137 M
Shares Outstanding
124 M
Revenue
2 343 K
EPS
-0.21
Beta
0.977
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Milestone Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Milestone Pharmaceuticals Inc data using free add-ons & libraries
Get Milestone Pharmaceuticals Inc Fundamental Data
Milestone Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 2 343 K
- EBITDA: -78 207 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Milestone Pharmaceuticals Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-12
- EPS/Forecast: -0.18
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Milestone Pharmaceuticals Inc News
New
Milestone Pharmaceuticals Q2 Earnings Call Highlights
Key Points Interested in Milestone Pharmaceuticals Inc.? Here are five stocks we like better. CARDAMYST gained early commercial momentum after its mid-February launch, with more than 1,200 second-qua...
Milestone Pharmaceuticals shares tumble after Q2 earnings miss
Medical researcher pouring liquid into a beaker ©Adobe Stock Images Milestone Pharmaceuticals Inc. (NASDAQ:MIST) shares dropped 12.60% on Wednesday after the biopharmaceutical company reported a sec...
Here are the major earnings before the open Wednesday
Major earnings expected before the bell on Wednesday include: * Nebius Group N.V. (NBIS [https://seekingalpha.com/symbol/NBIS]) * Tencent Holdings Limited (TCEHY [https://seekingalpha.com/symbol/...
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MONTREAL and CHARLOTTE, N.C., July 02, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity ...
Get Milestone Pharmaceuticals Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
